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We report the results of a genomewide scan for age-related macular degeneration (AMD) in 158 multiplex families.
AMD classification was based on fundus photography and was assigned a grade ranging from 1 (no disease) to 5
(exudative disease). Genotyping was performed by the National Heart, Lung, and Blood Institute Mammalian
Genotyping Service at Marshfield (404 short tandem repeat markers). The sample included 158 families with two
or more siblings with AMD, 490 affected individuals, 101 unaffected individuals, and 38 whose affection status
was unknown. Relative pairs included 511 affected sibling, 28 avuncular, 53 cousin, 7 grandparent-grandchild,
and 9 grand-avuncular pairs. Two-point parametric and multipoint parametric and nonparametric analyses were
performed. Maximum two-point LOD scores of 1.0–2.0 were found for markers on chromosomes 1, 2, 8, 10, 14,
15, and 22. Multipoint analyses were consistent with the two-point results for chromosomes 1, 2, 8, 10, and 22
and provided evidence for additional linkage regions on chromosomes 3, 6, 8, 12, 16, and X. Our signals on
chromosomes 1q, 6p, and 10q are consistent with some other previously published results. Significant linkage to
AMD was found for one marker on chromosome 2, two adjacent markers on chromosome 3, two adjacent markers
on chromosome 6, and seven contiguous markers on chromosome 8, with empirical P values of .00001. The
consistency of many of the other signals across both two-point and multipoint, as well as parametric and non-
parametric, analyses indicate several other regions worthy of follow-up.
Introduction
Age-related macular degeneration (ARMD1 [MIM
603075]; hereafter referred to as “AMD”) is the leading
cause of visual impairment and blindness among older
adults in the United States and all developed countries
around the world. It affects the central regions of the
retina and choroid and therefore can lead to central vi-
sual loss and inability to read, write, and drive, which
results in loss of independence. Approximately 30% of
individuals aged 75 years have some sign of the dis-
ease, and ∼6%–8% of those in this age group have the
advanced stages that cause visual loss (National Advi-
sory Eye Council 2001). The prevalence of this impor-
tant eye disease will continue to rise as the population
ages. Since treatment options are limited to a small sub-
set of patients and have short-term effects, it is imper-
ative to identify the causes of this disease so that it can
be prevented.
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Familial aggregation has been demonstrated for AMD
(Seddon et al. 1997; Klaver et al. 1998b; Klein et al.
2001). It is likely that both genetic susceptibility (Heiba
et al. 1994; Allikmets et al. 1997; De Jong et al. 1997;
Seddon et al. 1997; Klaver et al. 1998b; Klein et al. 1998,
2001; Allikmets 2000; Weeks et al. 2001; Hammond et
al. 2002) and environmental risk factors (The Eye Disease
Case-Control Study Group 1992; Seddon et al. 1996;
Seddon 2001) play a role. The relative paucity of infor-
mation about the specific genetic origins of AMD can be
attributed to several factors. Unlike juvenile-onset retinal
diseases with clear Mendelian inheritance for which ge-
netic causes have been identified, AMD occurs late in life,
typically only one generation has the disease phenotype,
parents and some of the siblings are often deceased, and
the offspring are too young to manifest the disease. Fur-
thermore, considerable evidence indicates that the path-
ogenesis of AMD is multifactorial, involving a combi-
nation of genetic, environmental, and biologic factors.
At this point, the evidence for environmental risk factors
appears to be more clearly delineated than evidence for
any particular gene.
Cigarette smoking (Seddon et al. 1996; Smith et al.
1996; Vingerling et al. 1996; Delcourt et al. 1998; Sed-
don 2001) and increasing age have been consistently
shown to be related to the onset of this disease. Several
other lifestyle and medical factors may possibly play a
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role, such as systemic hypertension (Sperduto et al.
1986; Friedman 1997; Hyman et al. 2000) and elevated
cholesterol levels (The Eye Disease Case-Control Study
Group 1992). In addition, nutritional factors are related
to AMD (Seddon et al. 1994, 2001b; Mares-Perlman
et al. 1995; VandenLangenberg et al. 1998). Foods rich
in antioxidants may be protective, whereas fat con-
sumption is associated with an elevated risk for AMD
(Seddon et al. 2001b). Omega-3 fatty acids and fish
intake have been shown to have a beneficial effect (Cho
et al. 2001; Seddon et al. 2001b). A multicenter ran-
domized clinical trial demonstrated that a supplement
with vitamins C, E, beta-carotene, and zinc reduces the
risk of progression to the advanced forms of AMD and
subsequent visual loss among individuals with inter-
mediate stages of AMD (Age-Related Eye Disease Study
[AREDS] Research Group 2001b).
Genetic linkage to chromosome 1q has been reported
in one family with AMD (Klein et al. 1998). Weeks et
al. (2001) reported potential loci on chromosomes
1q31, 9p13, 10q26, and 17q25. This study corrobo-
rates the finding of Klein et al. (1998), in which linkage
to chromosome 1q25-q31 and loci on chromosomes 2
and 12 were also shown to have LOD scores 11.5. A
recent report by Schick et al. (2003) shows evidence for
suggestive linkage to early AMD on chromosomes 3, 5,
6, 12, 15, and 16, with the strongest evidence for linkage
on chromosome 12 near D12S46.
We hypothesize that underlying susceptibility gene(s)
are critical to the development of AMD and that they
most likely interact with environmental factors and pos-
sibly other genes to trigger the development and pro-
gression of this disease. We are therefore conducting
both candidate-gene searches and genomic screening to
identify these genes, in an effort to elucidate the etiology
of AMD. In this article, we report the results of a ge-
nomewide scan of multiplex families with affected sib-
ling pairs.
Material and Methods
Recruitment of Families and Clinical Procedures
The methods employed in this study conformed to the
tenets of the Declaration of Helsinki and received ap-
proval from the institutional review board at the Mas-
sachusetts Eye and Ear Infirmary, Boston. Informed con-
sent statements were signed by probands and family
members who participated in this study.
Families with two or more siblings reported to have
AMD were eligible for recruitment into the study. Po-
tentially eligible probands were recruited from several
sources, including the AMD database of the principal
investigator (J.M.S.), from other ophthalmologists
throughout the country, from some of the clinical centers
participating in a multicenter randomized trial of vita-
mins and minerals (AREDS), and through various media
such as newsletters, brochures, and newspapers. After
obtaining written consent, all records and photographs
were obtained from eye doctors and reviewed by J.M.S.
Families with two or more living siblings with diagnoses
of AMD (large drusen, geographic atrophy, or exudative
disease) were then asked to participate.
Data collection procedures included an ocular exami-
nation, ocular fundus photography, blood drawing, and
questionnaires about risk factors for AMD. We developed
protocols and standardized forms for data collection,
which were sent to a participating ophthalmologist near
the subject’s home for use during the examination. Prior
to the examination of a participant, J.M.S. called the oph-
thalmologist to review these procedures and answer any
questions, to ensure uniformity and accuracy in data col-
lection techniques and procedures.
The ocular examination consisted of assessment of
refractive error, best-corrected visual acuity, intraocular
pressure, and notation of iris color compared with stan-
dard photographs (Seddon et al. 1990). After dilation
of the pupils, cataract status was recorded by comparing
the slit-lamp examination to standard photographs
(LOCS II) (Chylack et al. 1993). Signs of macular de-
generation were evaluated with the aid of example pho-
tographs that were chosen from the clinical files of J.M.S.
The photographs depicted small hard drusen and retinal
pigment epithelial hyperpigmentation and hypopigmen-
tation, as well as geographic atrophy, retinal pigment
epithelial detachment, and signs of choroidal neovas-
cularization, including disciform scarring. Retinal pho-
tography was performed according to the standard pro-
tocol we provided, which required stereo pair 30 fundus
photographs centered on the optic disc, fovea, and tem-
poral to the fovea of each eye. Blood specimens were
obtained for genetic analyses, as well as for biochemical
analyses to assess the effect of various potential bio-
markers on the risk of AMD. DNA was extracted using
standard techniques.
Classification/Phenotype Assessment
Classification of AMD was based on fundus photog-
raphy in combination with the study examination data.
Macular characteristics seen on the photographs were
graded within an area with a 3,000-micron radius cen-
tered on the foveal center and included drusen, retinal
pigment epithelial irregularities, geographic atrophy, ret-
inal pigment epithelial detachment, and evidence for
choroidal neovascularization associated with AMD, in-
cluding disciform scarring. AMD status was assigned by
J.M.S. according to our modification of the grading
system used in the AREDS (AREDS Research Group
2001a) as follows: grade 1, no evidence of AMD; grade
2, minimal maculopathy; grade 3, intermediate dry stage
of AMD; grade 4, geographic atrophy, the advanced
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Table 1
Fundus Characteristics Corresponding to AMD Grade
AMD
Grade Fundus Characteristics
1 No drusen or small nonextensive drusen without retinal
pigment epithelial abnormalities
2 Extensive hard drusen or nonextensive intermediate drusen,
and/or retinal pigment epithelial changes
3 Extensive intermediate drusen or any large drusen with or
without drusenoid retinal pigment epithelial detachment
4 Geographic atrophy
5 Exudative AMD including serous retinal pigment epithelial
detachment and choroidal neovascular membrane
6 Other maculopathy
form of dry AMD; and grade 5, the advanced, exudative
form of AMD (table 1). Past ocular records, photo-
graphs, and fluorescein angiograms were also reviewed,
when available, to confirm the diagnosis. Maculopathies
other than AMD, including those that could be associ-
ated with choroidal neovascularization, were noted and
excluded from the case group. To evaluate reliability of
the AMD grading, 222 photographs were sent to the
Wisconsin Fundus Photographic Reading Center for de-
tailed grading as used in the AREDS (AREDS Research
Group 2001a). The level of agreement between J.M.S.
and the Reading Center grade was determined using the
kappa statistic. The kappa statistic was 0.77 and the
weighted kappa was 0.84. Inconsistencies were adjudi-
cated by J.M.S., using all available clinical and photo-
graphic data.
Final AMD status for the genetic analysis was as-
signed, according to grade of AMD and age, as follows:
“AMD present” (grade 3, 4, or 5), “AMD not present”
(grade 1 or 2 if aged 60 years), or “unknown” (grade
1 or 2 if aged !60 years). Grade 3 represents a macu-
lopathy that is more likely to progress to the advanced
stages of AMD (Klein et al. 1997; AREDS Research
Group 2001b) and was included in the definition of
AMD. Grade 2, however, can occur in a large proportion
of individuals aged 160 years, and very few develop
advanced AMD (Klein et al. 1992, 1997; AREDS Re-
search Group 2001b); these individuals were therefore
not included as affected. Because individuals aged !60
years with grades 1 or 2 may develop maculopathy in
the future, they were designated as having unknown af-
fection status.
Genotyping
Genotyping was performed by the National Heart,
Lung, and Blood Institute (NHLBI) Mammalian Geno-
typing Service at Marshfield (Center for Medical Genetics
Web site), under the direction of J. Weber. A total of 404
STR markers from Weber Screening Set 10 were used,
397 of which were either autosomal or on the X chro-
mosome. Marker heterozygosity, excluding sex chromo-
some markers, ranged from 0.50 to 0.89 and averaged
0.7560.066. The average marker spacing across the ge-
nome was 9.26 cM.
Error Checking
Genotyping data were entered into a locally developed
data management system in the laboratory of S.L.S. Be-
cause there were very few parents or founders in the
data set, marker allele frequencies were recalculated
from the data via the USERM13 module of the program
Mendel (Lange et al. 1988; Mendel Web site), which
employs a maximum-likelihood method to provide un-
biased estimates of the allele frequencies based on data
from related individuals. Prior to statistical analysis, the
data were checked for Mendelian and sex inconsistencies
through use of the subroutine UNKNOWN from the
LINKAGE software package. We found 2,103 Mende-
lian and sex inconsistencies in the data. If it is assumed
that each inconsistency was due to one genotype or bin-
ning error, then the error rate is 0.0086, or 0.86%. For
cases in which the removal of one individual resolved
the inconsistency over several markers, that individual
was excluded from further analysis. For all other cases,
the inconsistent genotypes, which were generally specific
to one marker, were excluded. Sometimes this necessi-
tated the exclusion of entire families for certain markers.
Finally, we used the relationship estimation program
RELPAIR version 0.90 (Duren et al. 1997; Epstein et al.
2000; Center for Statistical Genetics Web site) to check
the accuracy of the stated relationships between indi-
viduals in a given pedigree against the actual level of
allele sharing across the genome. For instance, we used
RELPAIR to determine whether siblings who claim to
be full sibs are actually full or half sibs. The RELPAIR
software program infers the relationships of pairs of in-
dividuals on the basis of genetic marker data, either
within families or across an entire sample. It is based on
the pairwise likelihood ratio proposed by Boehnke and
Cox (Boehnke et al. 1997) that calculates the multipoint
probability of the observed marker genotypes, condi-
tioned on each relationship considered. Unlike some
other relationship checking programs, RELPAIR is able
to detect undiagnosed MZ twins. We found no errors
in relationships in any of the pedigrees.
Statistical Analyses
Two-point parametric analyses were run using the
MLINK module of FASTLINK version 4.1p (Cot-
tingham et al. 1993; Schaffer et al. 1994; Fastlink Home
Page) and were followed by multipoint parametric anal-
yses with the Genehunter version 2.1 (Kruglyak et al.
1996; Kruglyak Labs Web site) software package. It is
highly likely that AMD is oligogenic and may result from
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gene-by-environment as well as epistatic interactions.
Therefore, the correct model is unknown, and a single-
gene model for the disorder is almost certainly incorrect.
Nevertheless, it is generally accepted that, in the absence
of the correct model, it is possible to obtain increased
power to detect linkage by calculating LOD scores under
both a dominant and a recessive parametric model (Vie-
land et al. 1992; Durner et al. 1999) and allowing for
locus heterogeneity. Thus, for the two-point and mul-
tipoint parametric analyses, we calculated two LOD
scores, one dominant and one recessive, and report the
maximum of the two, the maximum LOD score (MLS).
For the multipoint analyses, we calculated the hetero-
geneity LOD score (HLOD) via the admixture model of
Smith (1963), as implemented in Genehunter, under both
a dominant and a recessive model. We report the max-
imum of the two (dominant and recessive) and hence-
forth refer to the maximum multipoint heterogeneity
LOD score as the MMHLS. The parameter estimates
used in the parametric models were as follows: for the
recessive model, the disease allele frequency ,qp 0.10
and penetrance values are and . Forf p f p 0 f p 0.51 2 3
the dominant model, the disease allele frequency qp
and penetrance values are and0.01 f p 0 f p f p1 2 3
.0.5
In addition, we used nonparametric or model-free
methods to assess evidence for linkage, in which speci-
fying the mode of inheritance (which is unknown for
AMD) is not required. We assessed the extent to which
the sib and other relative pairs shared ancestral alleles
identical by descent (IBD) by calculating nonparametric
Z scores (NPL scores), first using Genehunter version
2.1 and then using MERLIN version 0.8.8 (Abecasis et
al. 2002; MERLIN Web site), combined with SimWalk2
version 2.83 (Weeks et al. 1995; Sobel and Lange 1996;
Statgen Software Web site). Since some pedigrees in the
data set were too large to be analyzed with MERLIN,
we used SimWalk2 in combination with MERLIN to
handle the larger pedigrees. MERLIN calculates exact
results for the sib pairs and other relative pairs, and
SimWalk2 uses Markov Chain Monte Carlo methods to
estimate results for the combined sample of relative pairs
and larger pedigrees, which couldn’t be analyzed with
MERLIN. In Genehunter, we chose the Spairs option to
calculate the NPL scores (labeled “NPLpairs” in table 3
below). The Spairs option assesses pairwise allele sharing
among all affected relatives by counting the number of
pairs of alleles from the affected members of a family
that are shared IBD (Whittemore et al. 1994; Kruglyak
et al. 1996). The MERLIN/SimWalk2 output reports
clustering statistic D, which is very similar to the Whit-
temore and Halpern Spairs statistic as implemented in
Genehunter. Statistic D, like Spairs, is a pairwise statistic.
It measures the extent of IBD gene sharing among af-
fected relative pairs by summing over their kinship co-
efficients (Sobel and Lange 1996). The power of such
clustering statistics is increased in SimWalk2 by use of
the information in the unaffecteds as well as the affecteds
to sample all the IBD configurations, proportional to
their true likelihood. In tables 3 and 4 below, we use
the term “NPLpairs” to indicate both the Genehunter Spairs
statistic (table 3), and the P value of the SimWalk2 sta-
tistic D (table 4), since the two statistics are so similar.
Results
Of the 7,107 families screened to date, 6,208 did not
meet the eligibility criterion requiring two or more living
affected siblings. Of the 899 families reported to be po-
tentially eligible, 75% did not have two or more living
siblings with AMD or had relatives with other macu-
lopathies or retinal disease (diabetic retinopathy, vein
occlusion, epiretinal membrane, macular hole, etc.), and
a few eligible families refused to participate.
Of the 224 families that were enrolled, 198 completed
the study procedures. A sample of 158 of these families
(645 individuals) was genotyped with 404 microsatellite
markers. After exclusions for Mendelian inconsisten-
cies, the sample used for the analyses included 629 in-
dividuals, 401 women and 228 men. There were 490
affected individuals, with a mean age of 76.6 years and
a mean age at diagnosis of 69.9 years (grade 3 or
higher); 101 unaffected individuals, with a mean age of
70.3 years (grades 1 or 2, and over age 60 years); and
38 whose affection status was unknown. The sample
included 511 affected sibling pairs, as well as 13 parent-
child, 28 avuncular, 53 cousin, 7 grandparent-grand-
child, and 9 grand-avuncular pairs.
Table 2 lists the results of the two-point parametric
analyses; all LOD scores 11.0 are listed in descending
order. In every case, the two-point MLSs were maxi-
mized under the dominant model. Marker locations are
given in Kosambi centimorgans from the telomere.
Markers on chromosomes 1, 2, 8, 10, 14, 15, and 22
had two-point MLSs between 1.0 and 2.0; the highest
was a MLS of 2.00 on chromosome 22 (ATA37D06;
42.8 cM). Although there were no significant or sug-
gestive linkage findings from the two-point analyses
(Lander et al. 1995), there were five markers with MLSs
between 1.5 and 2.0.
Tables 3 and 4 list the most interesting results from
the multipoint analyses. Figure 1 graphically displays
the plots of the NPLpairs scores from the Genehunter
analyses for each of the chromosomes.
From table 3, which summarizes the results of the
Genehunter parametric and nonparametric analyses, it
is clear that the signals on chromosomes 22 and 2 were
again among the highest. The Spairs option in Genehunter
yielded NPL scores of 2.32 at 186 cM and 2.03 at 191
cM on chromosome 2 ( and .02, respectively)Pp .01
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Table 2
Results of Two-Point Parametric Analyses
Chromosome Marker DNamea
Locationb
(cM) vc LOD P Value
22 ATA37D06 D22S1045 42.8 .19 2.00 .001
2 GATA65C03 D2S1391 186.2 .23 1.81 .002
8 AFM127xh2 D8S262 4.3 .22 1.67 .003
10 ATA22D02 D10S1222 156.3 .23 1.61 .003
14 ATA29G03Z D14S599 40.7 .24 1.54 .004
1 ATA4E02 D1S1589 192.1 .24 1.33 .007
15 GATA151F03 D1S1507 60.2 .23 1.06 .014
a Alternate marker name.
b Location is given in Kosambi centimorgans from the telomere.
c Recombination fraction, or distance from the marker.
and an NPL score of 2.20 at 36 cM on chromosome
22 ( ). The MMHLSs associated with thesePp .01
regions were 1.94 and 2.37 (both under the dominant
model) on chromosome 2 and 0.94 (dominant) on chro-
mosome 22. However, these analyses also implicated
four new regions, on chromosomes X, 3, 16, and 12,
that were not seen in the two-point results. Adjacent
markers on the X chromosome at 93 cM and 97 cM
produced NPL scores of 2.53 and 2.54, respectively
( ), with MMHLSs of 1.2 and 1.5 (both reces-Pp .006
sive); on chromosome 3, adjacent markers at 117 cM,
124 cM, and 129 cM yielded NPL scores of 1.67, 2.03,
and 1.86 ( , .02, and .03, respectively) andPp .05
MMHLSs of 1.50, 1.19, and 1.39 (all recessive). On
chromosome 16, there was an NPL score of 2.01
( ) and an MMHLS of 1.32 (dominant) at aPp .02
marker located at 81 cM, while a marker on chromo-
some 12 at 83 cM produced an NPL score of 1.71
( ) and MMHLS of 1.56 (recessive). Altogether,Pp .04
these analyses identified 10 regions on nine chromo-
somes (2 regions on chromosome 2) with either
MMHLS 11.0, NPL nominal P values !.05, or both.
Table 4 displays the results of multipoint nonpara-
metric analyses, through use of the combination of
MERLIN and SimWalk2. We report all P values !.05
for the NPLpairs statistic (SimWalk2 statistic D), as de-
fined above.
Results of the MERLIN/SimWalk2 analyses are quite
consistent with the Genehunter results (tables 3 and 4).
Both analyses identified the same regions on chromo-
somes 2, 22, 3, 16, 1, 10, 12, and 8. However, the X
chromosome signals identified by Genehunter were not
as strong in the MERLIN/SimWalk2 results, and the
MERLIN/SimWalk2 analyses identified a region on
chromosome 6 that was new. For several of the signals
that were identified by both multipoint analyses, the
level of significance assessed by the MERLIN/SimWalk2
analyses was much greater than that indicated by Gene-
hunter; there were 12 markers in four regions with P
values of .00001 with MERLIN/SimWalk2. However,
this apparent discrepancy in significance levels is not so
surprising, since it is well known that, although the
empirical P values calculated by SimWalk2 are some-
what conservative, the NPL score P values computed
by Genehunter are extremely conservative whenever the
IBD information is incomplete, as it almost always is
(Kong and Cox 1997). The conservative P values com-
puted by Genehunter are the result of the program’s
overestimation of the variance of the NPL statistic, and
this overestimation can be quite severe when informa-
tion on IBD status is very incomplete. In this situation,
the Genehunter P values can be unacceptably conser-
vative (Kong and Cox 1997)
Significant linkage to AMD was found for one marker
on chromosome 2, two adjacent markers on chromo-
some 3, two adjacent markers on chromosome 6, and
seven contiguous markers on chromosome 8 (table 4).
These findings await replication in a larger sample. In
addition, the consistency of many other signals across
the two-point and multipoint—as well as parametric
and nonparametric—analyses indicate several other
regions worthy of follow-up.
Discussion
This genomewide scan for AMD in 158 multiplex fam-
ilies with 511 affected sib pairs indicated several regions
with internally consistent evidence (from two-point,
multipoint, parametric, and nonparametric analyses) for
linkage to regions on chromosomes 1, 2, 3, 8, 10, 12,
16, and 22. In addition, regions on chromosomes 6 and
23 (X) were identified by one of the multipoint analysis
methods. Significant linkage was found for regions on
chromosomes 2, 3, 6, and 8.
Our results on chromosome 1q are consistent with
those of Klein et al. (1998), who found significant link-
age in a large family, mapping to 1q25-31 between
markers D1S466 and D1S413 (at 198.3 and 212.4 cM,
respectively) and with those of Weeks et al. (2001), who
report HLODs 12.0 for three markers in this location,
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Table 3
Results of Multipoint Parametric and Nonparametric Analyses Using
Genehunter
Chromosome
and Locationa
(in cM) Marker
MMHLS
(Model)b ac
NPLpairs
Score P Valued
X:
92.9 DXS8084 1.19 (r) .13 2.53 .006
96.9 DXS998 1.53 (r) .17 2.54 .006
2:
64.3 D2S1356 .53 (d) .11 1.82 .03
77.6 D2S1352e 1.80 (d) .24 1.58 .06
90.8 D2S1394 .55 (d) .55 1.94 .03
186.2 D2S1391 1.94 (d) .24 2.32 .01
190.5 D2S1384f 2.37 (d) .29 2.03 .02
22:
36.2 D22S683 .94 (d) .17 2.20 .01
3:
117.1 D3S4529g 1.50 (r) .16 1.67 .05
124.2 D3S3045 1.19 (r) .12 2.03 .02
129.4 D3S2460h 1.39 (r) .14 1.86 .03
16:
81.2 GATA138C05 1.32 (d) .16 2.01 .02
1:
151.9 D1S534 .52 (d) .12 1.73 .04
170.9 D1S1679 .55 (d) .14 1.94 .03
192.1 D1S1589 2.41 (d) .25 1.95 .03
10:
156.3 D10S1222 1.90 (d) .27 1.73 .04
12:
83.2 D12S1052 1.56 (r) .16 1.71 .04
8:
4.3 D8S262 1.23 (r) .15 1.43 .08
a Location is given in Kosambi centimorgans from the telomere.
b Models are the same as for the two-point analyses. A “d” indicates
the MMHLS was maximized under the dominant model, and an “r”
indicates the MMHLS was maximized under the recessive model.
c Proportion of families with linkage to a given locus.
d P values indicate nominal (not genomewide) significance of NPL
scores and are known to be conservative.
e This signal, at 77.6 cM, falls between markers GATA27D04
(D2s1352), at 73.6 cM, and GATA8F03 (D2s1779), at 86.8 cM.
f This signal, at 190.5 cM, falls between markers GATA65C03
(D2S1391), at 186.2 cM, and GATA52A04 (D2S1384), at 200.4 cM.
g This signal, at 117.1 cM, falls between markers GATA128C0
(D3s4529), at 112.42 cM, and GATA84B12 (D3S3045), at 124.2 cM.
h This signal, at 129.4 cM, falls between markers GATA84B12
(D3s3045), at 124.2 cM, and GATA68F07 (D3s2460), at 134.6 cM.
Table 4
Results of Nonparametric Multipoint Analysis Using
MERLIN and SimWalk2
Chromosome
and Marker DNamea
Locationb
(cM)
NPLpairs
P Valuec
2:
GATA11H10 D2S1360 38.3 .00001
GATA69E12 D2S1394 90.8 .06
GATA65C03 D2S1391 186.2 .01
GATA52A04 D2S1384 200.4 .04
GATA30E06 D2S2944 210.4 .02
22:
GATA11B12 D22S683 36.2 .01
ATA37D06 D22S1045 42.8 .05
3:
GATA84B12 D3S3045 124.2 .04
GATA68F07 D3S2460 134.6 .00001
ATA34G06 D3S4523 138.0 .00001
16:
GATA138C05 Unknown 81.2 .04
1:
ATA4E02 D1S1589 192.1 .03
GATA48B01 D1S1660 212.4 .10
10:
ATA22D02 D10S1222 156.3 .05
12:
GATA26D02 D12S1052 83.2 .06
8:
GATA151F02 Unknown 27.4 .00001
AFM123xg5 D8S261 37.0 .00001
AFMa127ye5 D8S560 43.4 .00001
UT7129 D8S1048 54.3 .00001
GGAA20C10 D8S1477 60.3 .00001
GATA8G10 D8S1110 67.3 .00001
CGAA8G07 D8S113 77.9 .00001
6:
GATA64D02 D6S1053 80.5 .00001
ATA28B11 D6S1031 88.6 .00001
a Alternate marker name.
b Location is given in Kosambi centimorgans from the
telomere.
c P values are computed empirically, indicate nominal
(not genomewide) significance of NPL scores, and may
be conservative.
D1S1660, D1S1647, and D1S1678 (212.44–218.46
cM) in an extended genome scan for AMD. Our results
for chromosome 1 markers ATA4E02 and GATA48B01
(at 192.1 and 212.4 cM, respectively) are also internally
consistent across the two-point and multipoint analyses,
although they fall short of the criterion for suggestive
linkage. Taken together, the internal consistency of our
signal in this region of 1q, as well as the signals of Klein
et al. (1998) and Weeks et al. (2001), provide support
for a susceptibility locus on chromosome 1q.
Our finding of significant linkage (MERLIN/SimWalk
2; NPLpairs P value .00001) to two adjacent markers on
chromosome 6, at positions 80.5 and 88.6 cM, agrees
with the finding of possible linkage at locations at 84.0,
86.0, and 88.0 cM (P values .044, .042, and .044, re-
spectively) reported by Schick et al. (2003). In addition,
our linkage signal on chromosome 10 (D10S1222 at
156.3 cM) is within 20 cM of marker D10S1230, where
Weeks et al. found some evidence for linkage in both
the initial (Weeks et al. 2000) and extended (Weeks et
al. 2001) genome scans for AMD. In a separate study
of two large pedigrees (J.M.S., unpublished data), we
also observed some evidence for linkage at marker
D10S1693 (at 137.4 cM), within 5 cM of D10S1230.
With the exception of the possible role of mutations
in the ABCA4 gene (MIM 60169) in a small percentage
of cases of AMD (Allikmets et al. 1997; Allikmets
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Figure 1 Multipoint NPL analysis results for the AMD genome scan. Multipoint NPL scores were calculated with the Genehunter version
2.1 software package. In each graph, the chromosome number represented is indicated at the top of the chart, the NPL score is indicated on the
left vertical axis and is traced on the curve. The positions of the microsatellite markers and the length of each chromosome are indicated on the
horizontal axis.
2000), no gene has yet been identified as playing a major
role in the development of AMD. Candidate genes that
have been evaluated and found not to be associated with
AMD include TIMP3 (22q12.1-q13.2; MIM 188826)
(De La Paz et al. 1997), ELOVL4 (6q14.1; MIM
605512) (Ayyagari et al. 2001), VMD2 (11q13; MIM
153700) (White et al. 2000; Seddon et al. 2001a), RDS
(6p21.1-cen; MIM 179605) (Shastry et al. 1999), and
EFEMP1 (2p16; MIM 601548) (Stone et al. 1999).
Other genes, such as PON1 (7q21.3; MIM 168820)
(Ikeda et al. 2001), ACE (17q23; MIM 106180) (Hamdi
et al. 2002), SOD2 (6q25.3; MIM 147460) (Kimura et
al. 2000), APOE (19q13.2; MIM 107741) (Klaver et
al. 1998a; Souied et al. 1998), and CST3 (20p11.21;
MIM 604312) (Zurdel et al. 2002) have shown a pos-
itive association in at least one study.
We found no evidence for linkage on chromosomes
11 (VMD2), 7 (PON1), 17 (ACE), or 19 (APOE) in this
study. However, CST3 is within 30 cM of GATA47F05,
where we calculated a two-point MLS of 1.25 on chro-
mosome 20.
Although the SOD2 gene is located on chromosome
6, it is 180 cM away from our significant linkage peak
on that chromosome. However, chromosome 6 contains
a number of retinal genes—MCDR1 (6q15-q16.2; MIM
136550), RP25 (6q14-q21; MIM 602772), LCA5
(6q11-q16; MIM 604537), and RDS (6p21.1-cen; MIM
179605)—that are mapped to within 20 cM of our link-
age peak, including a newly identified gene located at
6q14 (Lagali et al. 2002).
Four genes, MERTK (2q14.1; MIM 604705) (Gal et
al. 2000), RP1 (8q11-q13; MIM 603937) (Liu et al.
2002), CORD9 (8p12-8q11; MIM unreviewed) (Dan-
ciger et al. 2001), and TTPA (8q13.1-q13.3; MIM
600415) (Yokota et al. 1996), might also be of potential
interest as candidate genes, because of their locations
on chromosomes 2 and 8.
Evaluation of the genetic contribution to late-onset
diseases such as AMD poses several challenges. Many
individuals in these families are young and have not yet
reached the age of risk, and many of the older family
members, particularly siblings and parents, have died.
Therefore, several generations with informative indi-
viduals are rarely available for genetic studies. Even
when large multiplex families are identified, there are
other notable challenges, including the relatively high
disease prevalence; ∼30% of individuals aged75 years
have some form of the disease, with 6%–8% having
the advanced stage causing visual loss (National Ad-
visory Eye Council 2001). This can lead to the ubiq-
uitous problems of genetic heterogeneity, wherein a dis-
ease may result from mutations in two or more different
and unrelated genes, and pleiotropy or phenotypic het-
erogeneity, in which a single gene may be expressed in
a variety of manifestations in different individuals, even
within the same families.
AMD is heterogeneous in its phenotypic appearance,
which also adds to its complexity. The broad spectrum
of clinical presentation of disease raises the question of
whether AMD is one disorder or perhaps several dis-
eases with different etiologies. This variable presenta-
tion and progression of AMD leads to difficulty and
imprecision in the classification of individuals as af-
fected. A quantitative-trait analysis based on a contin-
uous or ordinal scale of maculopathy could potentially
provide more power and precision in the mapping of
susceptibility genes for this relatively prevalent disorder.
A few such scales are under development at the present
time and may be useful tools for further genetic
investigations.
Furthermore, the interaction of behavioral and en-
vironmental factors shown to be associated with AMD,
such as smoking (Seddon et al. 1996) and nutritional
factors (Seddon et al. 1994; Mares-Perlman et al. 1995;
AREDS Research Group 2001b), may complicate ge-
netic studies. It is possible that even if an individual
inherits a putative susceptibility allele, that individual
may not manifest the disease if he or she has practiced
a protective lifestyle. Once one or more positional or
functional candidate genes are identified, it may be in-
formative to investigate gene-by-environment interac-
tions, through use of some of the known environmental
risk factors. It is also possible that there are several
susceptibility genes that act additively (genetic hetero-
geneity) or multiplicatively (epistasis), as well as gene-
by-environment interactions contributing to various
forms of AMD.
In summary, the present study identifies significant
linkage of AMD to regions on chromosomes 2, 3, 6,
and 8, as well as regions of potential interest, on chro-
mosomes 1, 10, 12, 16, 22, and X, that warrant further
study. In addition, our results provide some support for
the existence of potential candidate genes on chromo-
somes 1q, 10q, and 16q. AMD is most likely a complex
disorder with both genetic and environmental compo-
nents contributing to its development. Family-based as-
788 Am. J. Hum. Genet. 73:780–790, 2003
sociation studies and linkage disequilibrium analyses
will be useful tools as next steps for localizing AMD
susceptibility genes.
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